sinc
genet
cell
biolog
higher
eukaryot
extrem
complex
scientist
look
good
model
turn
use
yeast
simpler
system
studi
variou
patholog
includ
viru
prolifer
assay
new
drug
pathogen
agent
yeast
saccharomyc
cerevisia
simpl
eukaryot
organ
approxim
gene
inexpens
cultiv
exist
either
haploid
diploid
state
extrem
simpl
genet
manipul
complet
sequenc
yeast
genom
fruit
worldwid
collabor
laboratori
first
determin
eukaryot
cell
gene
assign
function
share
conserv
sequenc
least
one
known
predict
human
gene
http
wwwyeastgenomeorg
owe
high
conserv
fundament
biochem
pathway
yeast
use
model
unravel
biolog
process
mani
higher
eukaryot
short
review
see
import
tool
facilit
use
cell
avail
yeast
librari
nonessenti
gene
delet
use
multipl
studi
includ
genom
wide
screen
human
diseas
gene
host
factor
support
viru
replic
collect
commerci
avail
cover
yeast
gene
excit
exampl
benefici
use
model
system
found
two
recent
report
although
relat
viru
research
use
yeast
model
studi
sever
human
patholog
amyotroph
later
sclerosi
al
also
known
lou
gehrig
diseas
neurodegen
diseas
motor
neuron
central
nervou
system
control
muscl
die
lead
paralysi
death
within
year
onset
caus
diseas
unknown
treatment
stop
slow
gene
relat
al
call
fu
use
explor
biolog
yeast
highlight
potenti
model
element
complex
diseas
simpl
eukaryot
cell
result
studi
suggest
defect
rna
process
transport
may
key
element
al
pathophysiolog
cytoplasm
motor
neuron
al
patient
protein
aggreg
form
insolubl
aggreg
call
inclus
may
involv
fu
anoth
al
caus
protein
call
two
research
group
overexpress
human
fu
yeast
observ
cytoplasm
inclus
human
major
fu
found
nucleu
alsassoci
mutat
reduc
nuclearcytoplasm
ratio
protein
suggest
transfer
cytoplasm
rather
mutat
may
import
patholog
hypothesi
support
observ
decreas
overexpress
wildtyp
fu
yeast
nucleu
diminish
toxic
effect
fu
rna
bind
protein
genomewid
screen
identifi
yeast
gene
specif
decreas
cell
toxic
perform
identifi
gene
includ
code
dnarna
bind
protein
one
yeast
gene
call
human
homolog
found
elimin
toxic
among
function
play
import
role
mrna
qualiti
control
support
idea
pathway
involv
rna
defect
fusinduc
al
interestingli
express
abl
rescu
fu
toxic
yeast
without
drive
fu
inclus
send
back
nucleu
suggest
may
possibl
overcom
therapeut
effect
abnorm
local
fu
without
address
difficult
problem
restor
origin
compart
two
import
consequ
may
result
approach
identifi
new
gene
diminish
alslink
toxic
point
rna
process
therapeut
target
diseas
also
shown
yeast
potenti
much
simpler
excit
system
model
aspect
al
sinc
test
idea
pathogenesi
treatment
much
faster
cheaper
yeast
result
may
open
way
rapid
progress
understand
diseas
treatment
role
new
gene
al
develop
import
detail
neurodegen
diseas
obtain
use
yeast
exampl
protein
misfold
associ
mani
human
diseas
includ
alzheim
parkinson
huntington
diseas
studi
yeast
case
al
mention
protein
misfold
often
result
format
intracellular
extracellular
inclus
whose
role
protein
misfold
diseas
unclear
studi
implic
protein
aggreg
toxic
yeast
provid
excel
experiment
conceptu
paradigm
contribut
understand
differ
toxic
protect
role
protein
conform
chang
result
studi
use
yeast
potenti
transform
basic
concept
protein
fold
human
diseas
may
help
identifi
new
therapeut
strategi
treatment
viru
research
cerevisia
use
organ
term
public
health
use
yeast
produc
vaccin
remark
breakthrough
exampl
first
recombin
vaccin
hepat
b
surfac
antigen
express
yeast
becom
safe
effici
prophylact
vaccin
worldwid
addit
yeast
prove
use
drug
discoveri
illustr
power
appli
genom
approach
use
yeast
model
character
biolog
activ
small
molecul
identifi
cellular
target
import
step
toward
understand
mode
action
human
therapeut
agent
studi
recent
report
show
path
sequenc
function
analysi
direct
therapeut
applic
necessarili
long
least
use
yeast
model
simpl
organ
could
well
consid
among
man
best
friend
basic
research
virolog
yeast
assist
elucid
function
individu
protein
import
pathogen
virus
hepat
c
viru
epsteinbarr
viru
review
refer
see
furthermor
studi
virus
infect
yeast
provid
mani
import
contribut
dissect
life
cycl
mani
higher
eukaryot
rna
virus
host
factor
involv
studi
replic
rna
plant
virus
first
attempt
use
yeast
cell
great
major
rna
virus
carri
rna
polymeras
replic
cytoplasm
entri
nuclear
compart
viral
cycl
confin
retrovirus
see
first
higher
eukaryot
viru
report
replic
yeast
brome
mosaic
viru
positivestrand
rna
rna
viru
infect
plant
excel
review
see
sinc
pioneer
work
ahlquist
laboratori
grow
list
virus
report
undergo
replic
yeast
includ
rna
dna
virus
infect
plant
insect
mammal
human
tabl
wide
rang
virus
emphas
gener
applic
yeast
system
paper
focu
contribut
yeast
model
studi
retrovirus
special
emphasi
human
immunodefici
viru
type
yeast
twohybrid
system
also
call
doublehybrid
extens
use
search
character
potenti
partner
given
protein
review
see
basi
method
allow
search
character
protein
capabl
interact
known
protein
lead
obtain
clone
gene
interact
protein
plasmid
construct
encod
two
hybrid
protein
figur
one
hybrid
consist
dnabind
domain
yeast
transcript
activ
protein
fuse
known
protein
hybrid
consist
activ
domain
fuse
protein
sequenc
encod
librari
yeast
sourc
genom
dna
fragment
interact
known
protein
protein
encod
one
librari
plasmid
lead
transcript
activ
report
gene
easi
detect
contain
bind
site
addit
thousand
exampl
describ
literatur
use
system
mani
cellular
viral
partner
protein
detect
use
strategi
case
enzym
addit
studi
rt
proteas
sever
cellular
retrovir
partner
integras
describ
exampl
interact
human
ortholog
yeast
transcript
factor
describ
len
epitheliumderiv
growth
factor
latter
play
import
role
stimul
integr
step
facilit
interact
host
cell
chromatin
interact
microtubul
protein
use
twohybrid
approach
confirm
later
use
method
recent
develop
threehybrid
onehybrid
system
deriv
twohybrid
system
encod
enzymesal
retrovirus
carri
three
enzym
rna
dnadepend
dna
polymeras
revers
transcriptas
rt
integras
proteas
pr
see
organ
protein
sever
retrovirus
shown
figur
structur
shown
figur
rt
also
contain
addit
enzymat
activ
rnase
h
map
separ
contigu
portion
polypeptid
first
identifi
avian
virus
retrovir
enzym
organ
domain
gagpro
gagpropol
precursor
polypeptid
domain
alway
cleav
separ
matur
protein
genera
enzym
translat
togeth
gagpropol
precursor
process
yield
matur
form
enzym
whether
express
pro
pol
due
frameshift
termin
suppress
account
approxim
rt
molecular
basi
synthes
packag
virion
level
gag
protein
retrovirus
hold
pr
scheme
describ
retrovir
frameshift
process
shown
figur
sinc
rt
pr
essenti
viral
replic
characterist
distinguish
relat
cellular
enzym
becom
privileg
target
drug
acquir
immunodefici
syndrom
aid
time
assay
measur
rt
activ
vitro
assay
seem
attract
use
yeast
cerevisia
model
test
vivo
activ
enzym
purpos
construct
hybrid
retrotransposon
compos
endogen
yeast
element
revers
transcriptas
rt
shown
activ
yeast
saccharomyc
cerevisia
rt
activ
hybrid
element
monitor
use
simpl
genet
assay
revers
transcript
yeast
carri
hybrid
rt
depend
dna
polymeras
rnase
h
domain
rt
rt
inhibitor
divid
two
class
nucleosid
analog
rt
inhibitor
nrti
nonnucleosid
rt
inhibitor
nnrti
nrti
azt
ddi
dideoxyinosin
inhibit
revers
transcript
chaintermin
mechan
ad
grow
dna
chain
block
synthesi
nnrti
act
block
synthesi
bind
specif
hydrophob
pocket
rt
revers
transcriptas
activ
measur
yeast
cell
shown
sensit
inhibitor
rt
like
wellcharacter
nonnucleosid
rt
inhibitor
rt
hybrid
construct
express
nnrtiresist
rt
variant
insensit
yeast
specif
inhibit
assay
hybrid
rt
call
hart
element
carri
nnrtiresist
variant
rt
use
identifi
compound
activ
drugresist
virus
revers
transcriptas
enzym
purifi
viru
heterodim
subunit
kda
call
figur
subunit
shorten
version
cleavag
encod
proteas
mani
recombin
protein
yeast
cerevisia
use
express
rt
gene
subunit
carri
express
vector
use
surprisingli
recombin
enzym
purifi
express
yeast
heterodimer
form
protein
sequenc
show
cleavag
produc
subunit
gave
product
ident
nativ
viral
enzym
show
yeast
possess
proteas
exquisit
specif
proteas
catalyz
insert
provir
dna
hostcel
genom
gener
review
integras
refer
see
first
step
integr
reaction
term
process
two
nucleotid
remov
doubl
strand
viral
dna
produc
new
hydroxyl
end
reaction
occur
cytoplasm
within
larg
viral
nucleoprotein
complex
pic
enter
nucleu
via
pic
multimer
complex
process
viral
dna
join
coval
host
dna
join
reaction
includ
coupl
stagger
cleavag
target
host
dna
ligat
viral
dna
end
end
target
dna
although
mechan
fulli
understood
host
cell
dna
repair
enzym
probabl
accomplish
repair
remain
gap
compos
three
function
domain
ntermin
region
residu
character
hhcc
zinc
fingerlik
sequenc
abl
bind
zinc
bind
induc
proper
fold
n
terminu
promot
tetramer
central
region
residu
figur
b
character
three
highli
conserv
amino
acid
residu
form
catalyt
triad
dd
e
one
residu
essenti
enzym
activ
ctermin
region
least
conserv
domain
involv
nonspecif
dna
bind
structur
three
domain
determin
rmn
xray
crystallographi
despit
consider
effort
low
solubl
nativ
integras
hamper
determin
crystallograph
structur
entir
protein
three
domain
requir
vitro
process
dna
strand
transfer
mutat
analys
viral
integras
gene
show
enzym
requir
retrovir
replic
legitim
target
design
antiretrovir
drug
recent
structur
human
foami
retroviru
integras
determin
take
profit
increas
solubl
yield
recombin
retrovir
enzym
confirm
tetram
quaternari
structur
base
result
date
express
bacteri
restrict
endonucleas
express
yeast
cell
led
appear
lethal
phenotyp
idea
emerg
express
retrovir
also
carri
endonucleas
activ
may
produc
similar
phenotyp
idea
behind
approach
feasibl
system
may
allow
set
easi
rapid
procedur
screen
antiretrovir
drug
howev
weak
entranc
molecul
yeast
wall
cell
membran
hamper
project
yeast
model
extrem
use
studi
mani
aspect
integr
step
retrovir
replic
express
plasmid
contain
retrovir
integras
gene
control
induc
promot
regul
glucos
concentr
medium
construct
haploid
yeast
strain
appear
clearli
sensit
integras
express
figur
howev
disrupt
rad
gene
involv
repair
doublestrand
dna
break
strongli
increas
deleteri
effect
retrovir
enzym
yeast
strain
diploid
strain
construct
isogen
strain
opposit
mate
type
also
show
strong
sensit
lethal
phenotyp
suppress
missens
integras
mutat
catalyt
domain
known
abolish
activ
vitro
figur
subsequ
studi
perform
order
determin
critic
amino
acid
andor
motif
requir
induct
lethal
phenotyp
yeast
elucid
molecular
mechan
caus
phenotyp
mutant
locat
ctermin
region
catalyt
core
domain
shown
unabl
induc
lethal
phenotyp
yeast
mutagen
virolog
experi
led
conclus
mutat
inhibit
ininduc
lethal
phenotyp
yeast
inhibit
bind
host
chromatin
result
demonstr
ctermin
region
catalyt
core
domain
import
bind
host
chromatin
crucial
viral
replic
promot
ininduc
lethal
phenotyp
yeast
question
remain
whether
lethal
effect
relat
nonspecif
endonucleas
activ
viral
whether
mechan
involv
due
pleiotrop
effect
protein
lethal
yeast
seem
relat
mutagen
effect
recombin
probabl
via
nonsequencespecif
endonucleas
activ
carriedoutbi
enzym
nonsequencespecif
endonucleas
activ
character
although
enzym
activ
dna
substrat
devoid
viral
long
termin
repeat
ltr
sequenc
characterist
retrovir
provir
genom
presenc
ltr
region
significantli
stimul
activ
genet
experi
show
mutagen
effect
level
recombin
event
affect
cell
express
activ
retrovir
enzym
express
mutat
inact
signific
effect
mention
nucleoprotein
complex
pic
compris
provir
dna
viral
cellular
protein
form
cytoplasm
enter
nucleu
unknown
mechan
retrovir
dna
insert
host
nuclear
genom
exact
composit
pic
controversi
matter
sinc
differ
laboratori
describ
variou
viral
cellular
protein
yeast
twohybrid
system
use
identifi
human
gene
product
bind
tightli
human
immunodefici
viru
type
integras
vitro
stimul
dnajoin
activ
protein
suggest
part
pic
sequenc
gene
suggest
protein
human
homolog
yeast
transcript
activ
requir
highlevel
express
mani
gene
gene
term
integras
interactor
may
encod
nuclear
factor
promot
integr
target
incom
viral
dna
activ
gene
analog
yeast
human
ortholog
prompt
studi
whether
yeast
involv
lethal
effect
express
yeast
effect
inactiv
yeast
gene
encod
lethal
induc
yeast
express
describ
result
show
retrovir
unabl
perform
lethal
activ
cell
gene
disrupt
suggest
may
play
role
lethal
effect
induc
yeast
inactivationdo
affect
neitheryeast
viabil
express
given
homolog
human
counterpart
result
suggest
factor
may
import
activ
infect
cell
moreov
given
import
role
propos
transcript
factor
integr
step
fact
essenti
cell
viabil
interact
becom
potenti
target
search
new
antiretrovir
agent
given
proxim
mani
human
yeast
protein
express
human
rescu
lethal
phenotyp
yeast
cell
inactiv
reveal
function
analog
mani
human
yeast
gene
question
yet
fulli
answer
concern
cycl
mechan
entri
pic
nucleu
previou
integr
host
dna
question
intracellular
traffick
tackl
use
yeast
systembas
previou
result
use
twohybrid
strategi
show
interact
two
yeast
microtubuleassoci
protein
dynein
light
chain
protein
centrosom
protein
role
protein
intracellular
traffick
nuclear
import
yeast
studi
sinc
thought
biolog
mechan
evolutionarili
conserv
eukaryot
cell
found
accumul
perinuclear
microtubul
organ
center
mtoc
call
yeast
spindl
pole
bodi
spb
via
coloc
figur
disrupt
microtubul
network
nocodazol
express
yeast
strain
prevent
accumul
nuclear
peripheri
addit
inhibit
transport
nucleu
mutagenesi
result
indic
traffick
toward
spb
requir
cterminu
molecul
find
strongli
suggest
nuclear
import
seem
depend
essenti
intermedi
step
involv
spb
play
import
role
drive
toward
mtoc
optim
nuclear
entri
retrovir
enzym
intracellular
transport
yeast
cell
good
agreement
later
result
use
immunofluoresc
electron
microscopi
traffick
human
cell
tag
gfp
label
method
author
also
observ
accumul
label
nuclear
peripheri
involv
mtoc
cellular
voyag
nucleu
strong
similar
human
infect
cell
bud
yeast
demonstr
relev
yeast
model
obtain
detail
pictur
molecular
mechan
involv
cycl
figur
describ
express
yeast
absenc
viral
protein
abl
enter
nucleu
cleav
host
genom
excit
question
remain
whether
abl
integr
provirallik
dna
nuclear
yeast
genom
express
alon
solv
set
system
express
short
dna
mimick
retrovir
dna
carri
two
ltr
flank
antibiot
zeocin
resist
gene
figur
multipl
resist
yeast
clone
observ
condit
clone
obtain
use
construct
carri
inact
mutant
zeocinresist
clone
confirm
repres
real
integr
event
detect
bp
provirallik
dna
yeast
genom
dna
pcr
southern
experi
moreov
sequenc
integr
junction
show
integr
event
disrupt
differ
open
read
frame
sinc
sequenc
link
integr
ltr
target
dna
constitut
specif
signatur
involv
process
care
analyz
bp
repeat
character
hiv
integr
recov
clone
confirm
respons
process
therefor
simpl
eukaryot
model
retrovir
integras
viral
protein
necessari
insert
dna
contain
viral
ltr
genom
therebi
allow
studi
isol
integr
step
independ
viral
mechan
identif
yeast
factor
involv
traffick
remain
interest
perspect
anoth
issu
whether
cellular
factor
analog
form
pic
human
infect
cell
may
use
reconstitut
piclik
complex
moreov
result
may
indic
least
fraction
pool
integras
alon
may
enter
nucleu
independ
pic
last
step
integr
process
involv
repair
dna
junction
wide
report
cellular
dna
repair
system
play
crucial
role
retrovir
integr
step
dna
repair
factor
like
modul
process
effect
dna
repair
factor
easili
studi
yeast
sinc
contrari
observ
human
cell
deleteri
effect
observ
delet
yeast
delet
strike
increas
integr
event
observ
express
virallik
dna
yeast
recent
close
interact
molecular
mechan
play
protein
integr
describ
yeast
human
cell
vitro
integr
assay
perform
variou
condit
promot
inhibit
activ
demonstr
format
activ
nucleofila
requir
optim
inhibit
involv
dissoci
indna
complex
furthermor
avail
stimulatori
agent
made
possibl
show
inhibit
mechan
could
promot
cell
chemic
stimul
endogen
protein
stimul
induc
enhanc
endogen
dna
repair
process
inhibit
integr
step
result
show
restrict
viral
prolifer
pave
way
new
concept
antiretrovir
therapi
base
enhanc
endogen
recombin
activ
lethal
effect
similar
obtain
express
yeast
observ
recent
retrovirusencod
proteas
pr
figur
c
express
saccharomyc
cerevisia
mammalian
cell
find
contribut
deeper
understand
cytopathogenesi
express
pr
stop
yeast
growth
follow
cell
lysi
lytic
phenotyp
includ
loss
plasma
membran
integr
cell
wall
breakag
lead
releas
cell
content
medium
interestingli
effect
seem
specif
pr
sinc
neither
polioviru
proteas
protein
highli
toxic
cerevisia
abl
produc
similar
effect
drastic
alter
membran
permeabl
preced
lysi
yeast
express
pr
morpholog
chang
express
pr
yeast
mammalian
cell
similar
mani
aspect
encod
protein
vpr
viral
protein
r
play
sever
role
replic
cycl
retroviru
thu
propos
vpr
regul
nuclear
import
preintegr
complex
pic
carri
provir
dna
viral
integras
viral
cellular
protein
also
requir
replic
nondivid
cell
like
macrophag
much
evid
indic
abl
induc
arrest
cell
cycl
step
prolifer
cell
latter
effect
like
play
import
role
immunosuppress
process
aid
patient
recent
review
see
sever
line
evid
yeast
human
cell
show
vpr
import
effect
transit
cell
cycl
report
induct
vpr
express
fission
yeast
schizosaccharomyc
pomb
lead
sever
defect
assembl
function
mitot
spindl
spindl
pole
bodi
protein
deloc
vprexpress
yeast
cell
perturb
integr
addit
nuclear
envelop
structur
contractil
actin
ring
format
cytokinesi
also
disrupt
similar
problem
mitosi
cytokinesi
observ
human
cell
suggest
defect
account
patholog
effect
associ
infect
vpr
express
fission
yeast
schizosaccharomyc
pomb
induct
cell
death
observ
reminisc
effect
infect
mammalian
cell
suggest
vpr
may
affect
conserv
cellular
process
recent
year
protein
identifi
vpr
suppressor
abl
overcom
vprinduc
cell
death
fission
yeast
well
arrest
vprinduc
apoptosi
mammalian
cell
although
conclus
result
may
suggest
vprinduc
cell
death
yeast
resembl
apoptot
process
mammalian
cell
like
vprinduc
apoptosi
mammalian
cell
mitochondria
play
essenti
role
vpr
yeast
promot
phosphatidylserin
extern
induc
hyperpolar
mitochondria
lead
chang
mitochondri
membran
potenti
moreov
vpr
trigger
product
reactiv
oxygen
speci
ro
indic
cell
death
via
apoptoticlik
mechan
might
mediat
reactiv
speci
mitochondria
play
crucial
role
apoptosi
intrigu
fission
yeast
vpr
induc
uniqu
morpholog
chang
organel
vpr
suppressor
factor
suppress
vprinduc
apoptosi
mammalian
abolish
cell
death
mediat
vpr
restor
normal
mitochondri
morpholog
yeast
cell
similar
vprinduc
cell
death
fission
yeast
mammalian
apoptot
process
reinforc
idea
fission
yeast
may
use
simpl
model
organ
studi
apoptoticlik
process
induc
vpr
proapoptot
agent
rev
kda
phosphoprotein
discov
capabl
import
nucleu
bind
special
rev
respons
element
rre
viral
sequencespecif
rna
rev
abl
form
multim
direct
nuclear
export
larg
rrecontain
rnp
complex
rev
activ
crucial
nuclear
export
introncontain
rna
rev
shuttl
nucleu
cytoplasm
nuclear
local
signal
nl
well
nuclear
export
signal
ne
essenti
peptid
motif
shown
function
access
cellular
signalmedi
pathway
nuclear
import
nuclear
export
addit
nl
ne
nuclear
import
inhibitori
signal
ni
inhibit
entri
low
molecular
weight
protein
describ
rev
rev
therefor
excel
system
studi
aspect
transport
across
nuclear
envelop
human
immunodefici
viru
type
replic
requir
express
two
class
viral
mrna
earli
class
transcript
fulli
splice
encod
viral
regulatori
gene
product
function
express
rev
induc
cytoplasm
express
unsplic
incomplet
splice
mrna
encod
viral
structur
protein
includ
gag
env
base
experi
indic
similar
function
rev
yeast
cerevisia
yeast
protein
interact
effector
domain
rev
found
protein
call
novel
small
nucleoporinlik
protein
associ
nuclear
pore
closest
known
yeast
rel
nuclear
pore
compon
also
involv
mrna
transport
nucleu
cytoplasm
analysi
yeast
strain
overexpress
delet
gene
show
import
effect
rev
gene
express
indic
physic
interact
function
signific
vivo
result
suggest
rev
directli
promot
cytoplasm
transcript
transport
target
nuclear
pore
ne
domain
rev
protein
requir
revmedi
rna
export
mammal
well
yeast
saccharomyc
cerevisia
mention
rev
ne
shown
specif
interact
human
yeast
protein
twohybrid
assay
interact
protein
relat
fg
nucleoporin
basi
presenc
typic
repeat
motif
rev
abl
interact
multipl
fg
repeatcontain
nucleoporin
cerevisia
mammal
moreov
abil
rev
ne
mutant
interact
fg
nucleoporin
parallel
abil
mutant
promot
rna
export
yeast
xenopu
oocyt
mammalian
cell
revmedi
nuclear
export
viral
rna
involv
interact
leucinerich
ne
nuclear
cofactor
use
extens
panel
nuclear
export
posit
neg
mutant
function
homolog
ne
rev
physiolog
signific
interact
human
ness
variou
viral
sourc
demonstr
recent
cellular
factor
call
shown
essenti
nuclear
export
factor
interact
directli
nuclear
export
signal
includ
rev
ne
rangtpdepend
manner
shown
like
previous
describ
revinteract
protein
hriprab
sever
nucleoporin
also
interact
yeast
mammalian
cell
missens
mutat
yeast
nuclear
export
factor
abrog
rev
ne
interact
xxfg
repeatcontain
nucleoporin
rabhrip
mutat
minim
effect
interact
glfg
repeatcontain
function
analysi
domain
requir
nuclear
local
demonstr
entir
orf
requir
effici
incorpor
nuclear
envelop
put
nuclear
local
signal
identifi
downstream
glfg
repeat
region
wherea
overexpress
fulllength
aminotermin
glfg
repeat
region
uniqu
carboxytermin
region
induc
signific
suppress
hiv
unsplic
rna
export
lower
level
exogen
express
result
rel
modest
increas
unsplic
rna
export
result
suggest
physiolog
role
modul
revdepend
rna
export
hiv
infect
ni
signal
encod
rev
use
therapeut
agent
anticandid
effect
addit
properti
use
studi
mechan
action
factor
studi
intracellular
local
peptid
result
show
rev
rapidli
accumul
fungal
cell
surfac
cell
wall
regener
test
also
indic
rev
exert
anticandid
activ
fungal
plasma
membran
rather
cell
wall
use
fluoresc
probe
membranedisrupt
mechan
rev
confirm
suggest
may
potenti
therapeut
agent
treat
fungal
diseas
caus
candida
speci
human
studi
show
antifung
effect
nuclear
entri
inhibitori
signal
peptid
rev
protein
hemolyt
effect
retrovir
frameshift
see
chang
read
frame
gene
express
mechan
allow
keep
low
level
synthesi
rate
function
protein
rel
structur
protein
use
cerevisia
deciph
viral
frameshift
mechan
wilson
et
al
first
provid
vivo
demonstr
frameshift
event
cerevisia
insert
gagpol
fragment
contain
potenti
frameshift
site
without
stimulatori
element
yeast
express
plasmid
upstream
interferon
ifn
cdna
monitor
product
frameshift
protein
western
blot
clear
stimulatori
secondari
structur
requir
maxim
frameshift
effici
although
precis
natur
structur
remain
unclear
long
time
result
use
dual
report
system
yeast
show
direct
correl
hiv
frameshift
effici
stabil
stem
loop
stem
loop
analyz
studi
upper
part
complet
stimulatori
element
observ
nmr
condit
stabil
structur
clearli
link
frameshift
effici
structur
recent
identifi
basi
complet
yeast
genom
sequenc
seem
interest
explor
frameshift
effici
complet
sequenc
structur
tetraloop
similar
motif
found
rnase
iii
recognit
site
cerevisia
acaa
motif
tetraloop
poorli
recogn
rnase
iii
possibl
engin
cerevisia
rnase
iii
select
target
tetraloop
follow
express
protein
cell
suggest
hypothet
approach
remain
confirm
would
provid
interest
therapeut
strategi
deriv
experi
yeast
limit
prolifer
similar
slippag
effici
hiv
frameshift
site
vivo
yeast
vitro
mammalian
system
demonstr
high
level
conserv
frameshift
mechan
bidou
et
al
suggest
demonstr
frameshift
conserv
yeast
human
pave
way
use
yeast
mutant
analyz
retrovir
frameshift
alreadi
report
sever
group
virus
instanc
sar
coronaviru
sometim
shorten
sarscov
viru
caus
sever
acut
respiratori
syndrom
sarscov
carri
frameshift
signal
minim
frameshift
signal
viru
u
uua
aac
slipperi
sequenc
stimulatori
structur
fold
pseudoknot
pseudoknot
sever
unusu
featur
includ
third
stem
loop
presenc
two
unpair
adenosin
residu
within
structur
plant
dinman
demonstr
abil
new
site
frameshift
cerevisia
frequenc
frameshift
yeast
much
lower
coronaviru
site
test
yeast
infecti
bronchiti
viru
ibv
may
indic
exist
subtl
differ
term
frameshift
mechan
inde
import
unpair
adenosin
residu
remain
unclear
part
pseudoknot
thought
lie
outsid
ribosom
would
interest
investig
possibl
bind
transact
factor
although
bind
factor
never
detect
wellstudi
ibv
coronaviru
pseudoknot
yeast
mutant
known
specif
defect
frameshift
carri
alter
form
ribosom
protein
ribosom
peptidyltransferas
center
strain
report
slightli
higher
sarscov
frameshift
effici
wildtyp
strain
first
demonstr
newli
discov
frameshift
site
use
summari
although
much
potenti
promis
yeast
still
reveal
prove
extrem
valuabl
viru
research
addit
techniqu
like
doublehybrid
system
simpl
eukaryot
cell
use
produc
recombin
viral
protein
whose
purif
nativ
virion
difficult
simpli
imposs
also
allow
mechan
action
viral
protein
studi
thank
close
analog
human
yeast
protein
led
emerg
new
therapeut
target
associ
toxic
phenotyp
induc
viral
protein
yeast
cell
genet
manipul
facilit
entri
drug
potenti
therapeut
properti
may
becom
possibl
establish
simpl
cheap
system
allow
faster
screen
antivir
agent
futur
moreov
futur
work
lead
discoveri
new
cellular
factor
involv
viru
prolifer
thu
shorten
time
necessari
develop
new
therapi
current
new
virus
ultim
inform
behavior
virus
viru
protein
insid
cell
attain
plant
anim
human
cell
vivo
whole
organ
although
may
difficult
costli
laboratori
develop
approach
sinc
experi
yeast
alway
technic
easier
rapid
cheaper
human
complex
eukaryot
cell
yeast
remain
method
choic
studi
viru
infect
mechan
search
new
drug
target
